Tissue Microarray Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Tissue Microarray Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the tissue microarray market has seen robust growth. The market, which was valued at $12.05 billion in 2024, is projected to increase to $13.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.8%. Factors such as the emergence of precision medicine, advancements in drug discovery and development, efficacious analysis methods, an increase in chronic disease prevalence, and biobanking initiatives contributed to the growth during the historic period.

Tissue Microarray Market Size Forecast: What's the Projected Valuation by 2029?
The market for tissue microarray is anticipated to expand swiftly in the coming years, reaching a value of $20.95 billion by 2029, with a compound annual growth rate (CAGR) of 12.2%. The expected growth during the projection period could be due to the rise of digital pathology, broadening use cases, the expansion of the biopharmaceutical industry, regulatory backings and standards, as well as the integration of AI and machine learning. Key trends for the prediction period would include advancements in imaging technologies, the development of 3D tissue microarrays, high-volume screening, standardization efforts, and the incorporation of single-cell analysis.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

What Are the Drivers Transforming the Tissue Microarray Market?
The increase in the incidence of cancer is projected to stimulate the expansion of the tissue microarray market. Cancer is a type of disease that can emerge in any organ or tissue when irregular cells grow unchecked, exceeding their normal limits and either invading neighboring body parts or spreading to other organs. Tissue arrays are employed in the field of oncology to study the expression of cancer-related biomarkers in different tumor samples. For instance, the Macmillan Cancer Support, a cancer charity based in the UK, reported in June 2022 that the population of individuals living with cancer hit 3 million in 2022, predicted to increase to around 3.5 million by 2025 and 4 million by 2030 in the UK. Consequently, the rising incidence of cancer is fueling the growth of the tissue microarray market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

What Long-Term Trends Will Define the Future of the Tissue Microarray Market?
Strategic alliances are becoming an increasingly prominent trend in the tissue microarray industry. Major firms in this sector are forming partnerships to cultivate new collaborative efforts in developing tissue microarray technologies. To illustrate, The Cureline Group, a US firm specializing in HBS biobanking and lab services, formed a partnership with Cellecta Inc., a US company known for its RNAi and CRISPR screening products and services, in November 2022. This partnership, dubbed Tissue 2 Target Services, merges the unique skills of both firms in cell and tissue molecular analysis and management of human biospecimens, with the goal of providing pre-clinical and translational research services focused on gene target and biomarker discovery, thereby improving workflow efficiency. Additionally, in September 2022, Ultivue Inc., a biotech firm from the US that designs reagent-based solutions to extract the maximum biological data from cell and tissue samples, began a partnership with ngTMA of Switzerland's University of Bern. This partnership aims to advance multiplexed immunofluorescence (mIF) tests, introduce innovative TMA technologies, and facilitate spatial analysis in scientific studies, thereby escalating the quality of TMAs used in clinical and translational research.

Which Segments in the Tissue Microarray Market Offer the Most Profit Potential?
The tissue microarray market covered in this report is segmented -

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting
3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Which Firms Dominate the Tissue Microarray Market by Market Share and Revenue in 2025?
Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Which Regions Offer the Highest Growth Potential in the Tissue Microarray Market?
North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.